Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lipase, hormone-sensitive | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0037 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0657 | 0.0204 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.0657 | 0.5069 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.1296 | 0.1296 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.0462 | 0.3568 |
Loa Loa (eye worm) | hypothetical protein | 0.0253 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.1296 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0462 | 0.0462 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.1296 | 0.1296 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0 | 0.5 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0253 | 1 | 1 |
Echinococcus multilocularis | hormone sensitive lipase | 0.0253 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.1296 | 0.0874 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.1296 | 0.0874 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.0657 | 0.5069 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0462 | 0.0462 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0462 | 0.0462 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0253 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0462 | 0.0462 |
Brugia malayi | RNA binding protein | 0.0065 | 0.1296 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.1296 | 0.1296 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.1296 | 0.1296 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0462 | 0.0462 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.1296 | 0.1296 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0462 | 0.0462 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.0657 | 0.0204 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0462 | 0.0462 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.1296 | 0.1296 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0253 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.1296 | 0.0874 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.1296 | 0.1296 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.1296 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cmax (ADMET) | = 21 ng/ml | Cmax in Sprague-Dawley rat at 0.5 mg/kg, iv and 1 mg/kg, po | ChEMBL. | 17918819 |
F (ADMET) | = 12 % | Oral bioavailability in Sprague-Dawley rat at 1 mg/kg, po | ChEMBL. | 17918819 |
IC50 (binding) | = 0.25 uM | Inhibition of recombinant human hormone-sensitive lipase | ChEMBL. | 17918819 |
IC50 (binding) | = 0.25 uM | Inhibition of recombinant human hormone-sensitive lipase | ChEMBL. | 17918819 |
IC50 (binding) | > 50 uM | Inhibition of acetylcholine esterase | ChEMBL. | 17918819 |
IC50 (binding) | > 50 uM | Inhibition of butyrylcholine esterase | ChEMBL. | 17918819 |
IC50 (binding) | > 50 uM | Inhibition of acetylcholine esterase | ChEMBL. | 17918819 |
IC50 (binding) | > 50 uM | Inhibition of butyrylcholine esterase | ChEMBL. | 17918819 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.